NAALADL2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10000713
Fusion event
HBV-NAALADL2 integration
Validated
No
Detection method
HIVID
Data source
Curated
Sample type
Tumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2016
PubMed ID
27703150
Virus Sequence
Virus name
HBV
Reference genome
AF090842.1;AB033554.1;AB014381.1;M32138.1;AB032431.1;AB036910.1;AB064310;AY090454.1
Host Sequence
Chromosome
chr3
Cytoband
q26.31
Reference genome
GRCh37/hg19
Start
174356473/174638683 (Hg38)
End
174356473/174638683 (Hg38)
Location type
Intronic
Target gene
NAALADL2
Nearest miRNA
hsa-let-7g/Upstream/3531924; hsa-mir-1224/Downstream/730857;
Nearest TSS
ENST00000440867/Upstream/197696; ENST00000485853/Downstream/220597;
Nearest CpG islands
None/Target, chr3-CpG: 148/Upstream/197125, chr3-CpG: 133/Downstream/2557766
Nearby gene
NLGN1(-355334) ; NAALADL2(+220638) ;
Upstream sequence
GAATGGACTGTCAGATCAAACTCCTCCTAAAGCAAACAATAATTGCCTTAATTTTTGTGGATAGTACAGTTGGCTAAAATAAGCTAACCAGATTTGTGAA
Downstream sequence
ACTATAAAAATATGTTTTTGCATGCTGCATATTAACAGGATTCAGAAAAATTGGTGAAGGAATTTTTCCACATCAGTGAATTTTCCAATAAATACTTAGG
Reference
Zhao, L. H., et al.Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun ,2016,7: 12992.
Curate